Hudson Bay Capital Management’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.8K Sell
21,542
-16,193
-43% -$45.8K ﹤0.01% 1200
2026
Q1
$91.3K Hold
37,735
– – ﹤0.01% 1191
2025
Q4
$165K Buy
+37,735
New +$204K ﹤0.01% 987

Other funds holding GNLX

Hudson Bay Capital Management's GNLX Position: Q2 2026 in Review

Hudson Bay Capital Management reduced its Genelux (GNLX) stake by 43% in Q2 2026, selling an estimated $45.8K and leaving 21,542 shares worth $64.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1200.

Hudson Bay Capital Management first reported a position in GNLX in Q4 2025 and has held it in 3 quarters since. The position peaked at $165K in Q4 2025. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Hudson Bay Capital Management held 21,542 shares of Genelux worth $64.8K as of Q2 2026.
  • Hudson Bay Capital Management sold 16,193 Genelux shares in Q2 2026, an estimated $45.8K.
  • Genelux made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #1200 holding.
  • Hudson Bay Capital Management first reported a position in Genelux in Q4 2025 and has held it in 3 quarters since.
  • Hudson Bay Capital Management's Genelux position peaked at $165K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.